2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Application of Perioperative Transfusion Trigger Score in Patients Undergoing Surgical Treatment of Malignant Tumor

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The present study aimed to investigate the clinical effects of the brand new perioperative transfusion trigger score (POTTS) system in patients undergoing malignant tumor surgeries. 442 cases of patients diagnosed with malignant tumor were randomly selected (from January 2012 to December 2016) from Zunyi Medical University and were divided into 3 experimental groups. Patients in the POTTS group were transfused by the POTTS guideline perioperatively, while patients in the 7–10 g group were treated by the traditional transfusion guidelines existed (restrictive transfusion strategy), patients in the 10 g group should be transfused to keep the Hb level no less than 10 g/dL (liberal transfusion strategy). Baseline information, operation time, bleeding volume, transfusion amount, incision healing time, postoperative complications, metastasis and recurrence were observed and recorded. Postoperative short-term mortality was comparable of the 3 groups, 3 cases of death all occurred in 10 g group, there was no significant difference in the incidence of postoperative complications, including infectious complications and coagulation related complications. Follow-up to date, there were 25 cases, 29 cases and 29 cases of tumor recurrence and metastasis in the three groups, but no statistical difference observed. The present findings show that the POTTS transfusion system is more advantageous with regard to save blood and relieve economic burdens of patients, and does not affect the long-term recurrence and metastasis rate of malignant tumor.

          Related collections

          Author and article information

          Contributors
          zzbhaofan@sina.com
          Journal
          Indian J Hematol Blood Transfus
          Indian J Hematol Blood Transfus
          Indian Journal of Hematology & Blood Transfusion
          Springer India (New Delhi )
          0971-4502
          0974-0449
          12 September 2019
          January 2020
          : 36
          : 1
          : 156-163
          Affiliations
          [1 ] GRID grid.413390.c, Department of Anesthesiology, , The Affiliated Hospital of Zunyi Medical University, ; Zunyi, 563000 Guizhou People’s Republic of China
          [2 ] GRID grid.413390.c, Department of Pediatric Surgery, , The Affiliated Hospital of Zunyi Medical University, ; Zunyi, 563000 Guizhou People’s Republic of China
          [3 ] GRID grid.13291.38, ISNI 0000 0001 0807 1581, Department of Anesthesiology and Translational Neuroscience Center, West China Hospital, , Sichuan University, ; Chengdu, 610041 Sichuan People’s Republic of China
          [4 ] GRID grid.417409.f, ISNI 0000 0001 0240 6969, Department of Anesthesiology, , Zunyi Medical University, ; Zunyi, 563003 Guizhou People’s Republic of China
          Author information
          http://orcid.org/0000-0002-2750-2452
          Article
          PMC7042453 PMC7042453 7042453 1180
          10.1007/s12288-019-01180-z
          7042453
          32158099
          2b43ab89-f27d-43b2-8ac7-b93ec1a9cb68
          © Indian Society of Hematology and Blood Transfusion 2019
          History
          : 7 May 2019
          : 5 September 2019
          Funding
          Funded by: Guizhou Science and Technology Department of China
          Award ID: SY[2015]3051
          Award Recipient :
          Funded by: Special Fund of the Ministry of Health of China
          Award ID: 201002005
          Award Recipient :
          Categories
          Original Article
          Custom metadata
          © Indian Society of Hematology and Blood Transfusion 2020

          Prognosis,Transfusion,POTTS,Malignant tumor
          Prognosis, Transfusion, POTTS, Malignant tumor

          Comments

          Comment on this article